Progress in IBD depends on principled collaboration between clinicians, scientists, and the organisations that develop new therapies, devices, and technologies. We welcome pharmaceutical, medical device, diagnostic, and healthcare technology organisations as corporate partners of the Society.
Corporate partners support our scientific meetings, education, and community-building. In return, they gain visibility within a focused, multidisciplinary professional community and the opportunity to contribute to the growth of IBD care in Singapore.
Our commitment to integrity
Corporate partnership supports the Society, but never shapes its science. Corporate members do not vote, do not hold office, and have no influence over our clinical guidelines, scientific programme, or publications. Partners are expected to comply with the applicable industry codes, including the SAPI Code of Conduct for pharmaceutical companies and the APACMed Code of Ethical Conduct for medical technology companies. In keeping with our constitution, the identity of all corporate partners is disclosed publicly.
Current partners
Partner logo
Partner logo
Partner logo
Partner logo
Become a partner
To discuss corporate partnership, please contact us at partners@sgibd.org. We would be glad to share the ways your organisation can support the IBD community in Singapore.